CellFrame: A data structure for abstraction of cell biology experiments and construction of perturbation networks

Annals of the New York Academy of Sciences

Volumn 1115, Issue , 2007, Pages 249-266

  Gong, Yunchen ^a   Zhang, Zhaolei ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell perturbation; CellFrame; Database; Differential perturbation; Perturbation network; Reverse engineering

Indexed keywords

ASTROCYTOMA; ASTROCYTOMA CELL; CANCER CELL CULTURE; CELL SPECIFICITY; COLORECTAL CANCER; CONFERENCE PAPER; CYTOLOGY; CYTOMETRY; DATA ANALYSIS; DATA BASE; DATA COLLECTION METHOD; HUMAN; INFORMATION PROCESSING; INFORMATION SCIENCE; MODEL; NONHUMAN; QUANTITATIVE ANALYSIS; STIMULUS RESPONSE;

EID: 36249005452     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1407.010     Document Type: Conference Paper

References (57)

1. FENG, Z. et al. 2005. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. USA 102: 8204-8209.
2. MCKENZIE, S. & N. KYPRIANOU. 2006. Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J. Cell. Biochem. 97: 18-32.
3. SCHOEBERL, B. et al. 2002. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol. 20: 370-375.
4. FINNEY, A. & M. HUCKA. 2003. Systems biology markup language: level 2 and beyond. Biochem. Soc. Trans. 31: 1472-1473.
5. STROMBACK, L. & P. LAMBRIX. 2005. Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics 21: 4401-4407.
6. CHUNG, J.C., N. SCIAKY & D.J. GROSS. 1997. Heterogeneity of epidermal growth factor binding kinetics on individual cells. Biophys. J. 73: 1089-1102.
7. WILEY, H.S. 1988. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system. J. Cell. Biol. 107: 801-810.
8. KHOLODENKO, B.N. et al. 1999. Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem. 274: 30169-30181.
9. STARBUCK, C. & D.A. LAUFFENBURGER. 1992. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotechnol. Prog. 8: 132-143.
10. FRENCH, A.R. et al. 1995. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270: 4334-4340.
11. SERMON, B.A. et al. 1998. The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin. J. Biol. Chem. 273: 9480-9485.
12. SYDOR, J.R. et al. 1998. Transient kinetic studies on the interaction of Ras and the Ras-binding domain of c-Raf-1 reveal rapid equilibration of the complex. Biochemistry 37: 14292-14299.
13. OKADA, S., K. YAMAUCHI & J.E. PESSIN. 1995. Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors. J. Biol. Chem. 270: 20737-20741.
14. BATZER, A.G. et al. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol. Cell. Biol. 14: 5192-5201.
15. HUANG, C.Y. & J.E. FERRELL, JR. 1996. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 93: 10078-10083.
16. WIECHERT, W. 2002. Modeling and simulation: tools for metabolic engineering. J. Biotechnol. 94: 37-63.
17. JOSHI-TOPE, G. et al. 2005. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 33: D428-432.
18. LE NOVERE, N. et al. 2006. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res. 34: D689-691.
19. PAPIN, J.A. et al. 2005. Reconstruction of cellular signalling networks and analysis of their properties. Nat. Rev. Mol. Cell. Biol. 6: 99-111.
20. SACHS, K. et al. 2005. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308: 523-529.
21. ALFARANO, C. et al. 2005. The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res. 33: D418-424.
22. STARK, C. et al. 2006. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34: D535-539.
23. SALWINSKI, L. et al. 2004. The Database of Interacting Proteins: 2004 update. Nucleic Acids Res. 32: D449-451.
24. ERKMEN, O. 2001. Mathematical modeling of Escherichia coli inactivation under high-pressure carbon dioxide. J. Biosci. Bioeng. 92: 39-43.
25. TRUMMER, E. et al. 2006. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors. Biotechnol. Bioeng. 94: 1033-1044.
26. TAKAGI, M., T. MORIYAMA & T. YOSHIDA. 2001. Effects of shifts up and down in osmotic pressure on production of tissue plasminogen activator by Chinese hamster ovary cells in suspension. J. Biosci. Bioeng. 91: 509-514.
27. KARNAUGH, M. 1953. The Map Method for Synthesis of Combinational Logic Circuits. Trans. AIEE Comm. Electron. 72: 593-599.
28. LIANG, S., S. FUHRMAN & R. SOMOGYI. 1998. Reveal, a general reverse engineering algorithm for inference of genetic network architectures. Pac. Symp. Biocomput. :18-29.
29. GONG, Y. & Z. ZHANG. 2007. Alternative pathway approach for automating analysis and validation of cell perturbation networks and design of perturbation experiments. Ann. N. Y. Acad. Sci. 1407: XX-XX.
30. WALISZEWSKI, P. et al. 1997. Expression of retinoid-responsive genes occurs in colorectal carcinoma-derived cells irrespective of the presence of resistance to all-trans retinoic acid. J. Surg. Oncol. 66: 156-167.
31. KUBENS, B.S. & K.S. ZANKER. 1998. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Cancer Lett. 131: 55-64.
32. BERGMANN-LEITNER, E.S. & S.I. ABRAMS. 2000. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL. J. Immunol. 164: 4941-454.
33. VOELKEL-JOHNSON, C., Y.A. HANNUN & A. EL-ZAWAHRY. 2005. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein. Mol. Cancer Ther. 4: 1320-1327.
34. VAYTTADEN, S.J., S.M. AJAY & U.S. BHALLA. 2004. A spectrum of models of signaling pathways. Chembiochem 5: 1365-1374.
35. SIVAKUMARAN, S. et al. 2003. The Database of Quantitative Cellular Signaling: management and analysis of chemical kinetic models of signaling networks. Bioinformatics 19: 408-415.
36. ITOH, T. et al. 1993. A protein factor for ras p21-dependent activation of mitogen-activated protein (MAP) kinase through MAP kinase kinase. Proc. Natl. Acad. Sci. USA 90: 975-979.
37. KYRIAKIS, J.M. et al. 1992. Raf-1 activates MAP kinase-kinase. Nature 358: 417-421.
38. FERRELL, J.E., JR. & R.R. BHATT. 1997. Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J. Biol. Chem. 272: 19008-19016.
39. BURACK, W.R. & T.W. STURGILL. 1997. The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36: 5929-5933.
40. FERRELL, J.E., JR. & E.M. MACHLEDER. 1998. The biochemical basis of an all-ornone cell fate switch in Xenopus oocytes. Science 280: 895-898.
41. BHALLA, U.S. & R. IYENGAR. 1999. Emergent properties of networks of biological signaling pathways. Science 283: 381-387.
42. KHOLODENKO, B.N. 2000. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur. J. Biochem. 267: 1583-1588.
43. LEVCHENKO, A., J. BRUCK & P.W. STERNBERG. 2000. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc. Natl. Acad. Sci. USA 97: 5818-5823.
44. ASTHAGIRI, A.R. & D.A. LAUFFENBURGER. 2001. A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. Biotechnol. Prog. 17: 227-239.
45. BRIGHTMAN, F.A. & D.A. FELL. 2000. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett. 482: 169-174.
46. SWAIN, P.S. & E.D. SIGGIA. 2002. The role of proofreading in signal transduction specificity. Biophys. J. 82: 2928-2933.
47. SOMSEN, O.J. et al. 2002. Selectivity in overlapping MAP kinase cascades. J. Theor. Biol. 218: 343-354.
48. XIONG, W. & J.E. FERRELL, JR. 2003. A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature 426: 460-465.
49. GONG, Y. & X. ZHAO. 2003. Shc-dependent pathway is redundant but dominant in MAPK cascade activation by EGF receptors: a modeling inference. FEBS Lett. 554: 467-472.
50. MARKEVICH, N.I., J.B. HOEK & B.N. KHOLODENKO. 2004. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J. Cell. Biol. 164: 353-359.
51. GONG, Y. & Z. ZHANG. 2005. Alternative signaling pathways: when, where and why? FEBS Lett. 579: 5265-5274.
52. HUCKA, M. et al. 2003. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19: 524-531.
53. LLOYD, C.M., M.D. HALSTEAD & P.F. NIELSEN. 2004. CellML: its future, present and past. Prog. Biophys. Mol. Biol. 85: 433-450.
54. TAKAHASHI, K. et al. 2003. E-Cell 2: multi-platform E-Cell simulation system. Bioinformatics 19: 1727-1729.
55. SLEPCHENKO, B.M. et al. 2003. Quantitative cell biology with the Virtual Cell. Trends Cell. Biol. 13: 570-576.
56. WEBB, K. & T. WHITE. 2005. UML as a cell and biochemistry modeling language. Biosystems 80: 283-302.
57. TEGNER, J. & J. BJORKEGREN. 2007. Perturbations to uncover gene networks. Trends Genet 23(1): 34-41.